S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

Biotech Acquisition Stock Forecast, Price & News

-0.12 (-1.22%)
(As of 01/21/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
89,719 shs
Average Volume
42,623 shs
Market Capitalization
$280.31 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BIOT News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

About Biotech Acquisition

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.


See More Headlines

Industry, Sector and Symbol

Holding & other investment offices
Current Symbol
Year Founded

Sales & Book Value

Annual Sales


Pretax Margin




Free Float
Market Cap
$280.31 million
Not Optionable

Company Calendar

Fiscal Year End


Overall MarketRank

0.17 out of 5 stars

Unclassified Sector

411th out of 637 stocks

Holding & Other Investment Offices Industry

404th out of 594 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Biotech Acquisition (NASDAQ:BIOT) Frequently Asked Questions

Are investors shorting Biotech Acquisition?

Biotech Acquisition saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 12,700 shares, a drop of 28.2% from the December 15th total of 17,700 shares. Based on an average daily trading volume, of 120,900 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.1% of the company's stock are short sold.
View Biotech Acquisition's Short Interest

Who are Biotech Acquisition's key executives?

Biotech Acquisition's management team includes the following people:
  • Dr. Michael Shleifer Ph.D., Chairman & CEO (Age 47)
  • Mr. Thomas Fratacci, CFO & Treasurer (Age 43)
  • Mr. Ivan Jarry, Chief Operating Officer (Age 43)
  • Mr. Albert F. Hummel M.B.A., Chief Investment Officer & Director (Age 75)

What is Biotech Acquisition's stock symbol?

Biotech Acquisition trades on the NASDAQ under the ticker symbol "BIOT."

Who are Biotech Acquisition's major shareholders?

Biotech Acquisition's stock is owned by a variety of retail and institutional investors. Top institutional investors include Segantii Capital Management Ltd (0.17%).

Which major investors are buying Biotech Acquisition stock?

BIOT stock was bought by a variety of institutional investors in the last quarter, including Segantii Capital Management Ltd.

How do I buy shares of Biotech Acquisition?

Shares of BIOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biotech Acquisition's stock price today?

One share of BIOT stock can currently be purchased for approximately $9.75.

How much money does Biotech Acquisition make?

Biotech Acquisition has a market capitalization of $280.31 million.

How many employees does Biotech Acquisition have?

Biotech Acquisition employs 4 workers across the globe.

Where are Biotech Acquisition's headquarters?

Biotech Acquisition is headquartered at 545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY, 10001.

How can I contact Biotech Acquisition?

Biotech Acquisition's mailing address is 545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY, 10001. The company can be reached via phone at 212-227-1905.

This page was last updated on 1/22/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.